DEFA14A 1 ea172095-defa14a_noble.htm DEFINITIVE ADDITIONAL MATERIALS

 


 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

________________

Schedule 14A

________________

Information Required in Proxy Statement
Schedule 14A Information

Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934

 

Filed by the Registrant  
Filed by a Party other than the Registrant  

Check the appropriate box:

  Preliminary Proxy Statement
  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
  Definitive Proxy Statement
  Definitive Additional Materials
  Soliciting Material Pursuant to § 240.14a-12

Noble Rock Acquisition Corporation
(Name of Registrant as Specified in its Charter)

_________________________________________________________________

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box):

  No fee required.
  Fee paid previously with preliminary materials.
  Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

 

 

 

 

  

Noble Rock Acquisition Corporation

4001 Kennett Pike, Suite 302

Wilmington, DE 19807

 

SUPPLEMENT TO

PROXY STATEMENT DATED JANUARY 6, 2023

FOR EXTRAORDINARY GENERAL MEETING

OF

NOBLE ROCK ACQUISITION CORPORATION

 

Dear Shareholders of Noble Rock Acquisition Corporation:

 

You have previously received definitive proxy materials dated January 6, 2023 (the “Proxy Statement”) in connection with the extraordinary general meeting of Noble Rock Acquisition Corporation, a Cayman Islands exempted company (the “company”, “we”, “us” or “our”), to be held on January 25, 2023 at 10:00 A.M., Eastern time, at the offices of Loeb & Loeb LLP, located at 345 Park Avenue, New York, New York 10154 (the “general meeting”), or at such other time, on such other date and at such other place to which the meeting may be postponed or adjourned, and will be available to attend via teleconference. The purpose of this document is to supplement the Proxy Statement with certain new and/or revised information as follows:

 

No Conversion of Class B Ordinary Shares. In the Letter to Shareholders and page 13, we disclosed that the holders of the Class B Ordinary Shares intended to convert their shares into Class A ordinary shares. The holders of the Class B Ordinary Shares have decided they will not be doing so at this time.

 

Change in Terms for Extension. The sponsor has decided to change the amount to be deposited into trust in connection with any one-month extension from the lesser of (i) $110,000 and (ii) an aggregate amount equal to $0.06 multiplied by the number of public shares of the company that are not redeemed in connection with the shareholder vote to approve the extension proposal, to the lesser of (i) $100,000 and (ii) an aggregate amount equal to $0.055 multiplied by the number of public shares of the company not are not redeemed in connection with the shareholder vote.

 

Postponement of Extraordinary General Meeting and Extension of Redemption Deadline. Due to the changes described above, the company has decided to postpone its extraordinary general meeting to January 27, 2023 at 10:00 A.M. Eastern time. Shareholders will have until January 26, 2023 to submit a proxy or to revoke a previously-given proxy. The meeting will be held at the same location and accessible via teleconference at:

 

Within the U.S.:

1 877-853-5257 (toll-free)

Outside of the U.S.:

1 470-381-2552 (standard rates apply)

Meeting ID:

997 2158 0255

Passcode for telephone access:

279378#

 

The deadline for submission of public shares has been extended to 5:00 p.m. Eastern time on January 25, 2023.

 

Except as set forth herein, all other information in the Proxy Statement remains unchanged. If you have previously-submitted a proxy or tendered your shares for redemption in accordance with the procedures set forth in the Proxy Statement and you do not wish to make any changes, you do not need to do anything further.

 

This Proxy Supplement is Dated January 23, 2023